Avatrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia. Avatrombopag helps increase the production of platelets in the bone marrow. This medication is used in patients with chronic liver disease undergoing procedures and in patients with chronic immune thrombocytopenia.